Pdf Phase I And Pharmacokinetic Study Of Weekly Docetaxel Cisplatin

(PDF) Phase I and Pharmacokinetic Study of Weekly Docetaxel, Cisplatin ...
(PDF) Phase I and Pharmacokinetic Study of Weekly Docetaxel, Cisplatin ...
A phase I clinical and pharmacokinetic study of weekly docetaxel ...
A phase I clinical and pharmacokinetic study of weekly docetaxel ...
(PDF) Phase I and pharmacokinetic study of docetaxel combined with ...
(PDF) Phase I and pharmacokinetic study of docetaxel combined with ...
(PDF) A phase II study of weekly docetaxel and cisplatin plus oral ...
(PDF) A phase II study of weekly docetaxel and cisplatin plus oral ...
(PDF) Phase I and pharmacokinetic study of docetaxel in combination ...
(PDF) Phase I and pharmacokinetic study of docetaxel in combination ...
Phase I and pharmacokinetic study of docetaxel in combination with ...
Phase I and pharmacokinetic study of docetaxel in combination with ...
(PDF) Phase I clinical and pharmacokinetic trial of docetaxel and ...
(PDF) Phase I clinical and pharmacokinetic trial of docetaxel and ...
Phase I/II study of docetaxel and cisplatin with concurrent thoracic ...
Phase I/II study of docetaxel and cisplatin with concurrent thoracic ...
(PDF) A phase I and pharmacokinetic study of the combination of ...
(PDF) A phase I and pharmacokinetic study of the combination of ...
(PDF) Phase I clinical and pharmacokinetic study of trabectedin and ...
(PDF) Phase I clinical and pharmacokinetic study of trabectedin and ...
(PDF) Phase II Study of Docetaxel and Cisplatin as First-line ...
(PDF) Phase II Study of Docetaxel and Cisplatin as First-line ...
(PDF) A phase I and pharmacokinetic study of daily oral cediranib, an ...
(PDF) A phase I and pharmacokinetic study of daily oral cediranib, an ...
(PDF) Phase I and Pharmacokinetic Study of Gemcitabine Administered at ...
(PDF) Phase I and Pharmacokinetic Study of Gemcitabine Administered at ...
(PDF) A phase I dose-escalation and pharmacokinetic study of a micellar ...
(PDF) A phase I dose-escalation and pharmacokinetic study of a micellar ...
(PDF) A phase I clinical and pharmacokinetic study of paclitaxel and ...
(PDF) A phase I clinical and pharmacokinetic study of paclitaxel and ...
(PDF) Phase I Study of Concurrent and Consolidation Cisplatin and ...
(PDF) Phase I Study of Concurrent and Consolidation Cisplatin and ...
(PDF) Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil ...
(PDF) Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil ...
(PDF) Phase I and pharmacokinetic study of SPI-77, a liposomal ...
(PDF) Phase I and pharmacokinetic study of SPI-77, a liposomal ...
(PDF) Phase II Study with Docetaxel and Cisplatin in the Treatment of ...
(PDF) Phase II Study with Docetaxel and Cisplatin in the Treatment of ...
A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and ...
A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and ...
Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 ...
Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 ...
Table 1 from Phase I study of docetaxel, cisplatin and S-1 in patients ...
Table 1 from Phase I study of docetaxel, cisplatin and S-1 in patients ...
A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and ...
A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and ...
Figure 1. | Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil ...
Figure 1. | Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil ...
Table I. | Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil ...
Table I. | Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil ...
(PDF) A Phase I Dose Finding Study of Cisplatin, Gemcitabine, and ...
(PDF) A Phase I Dose Finding Study of Cisplatin, Gemcitabine, and ...
(PDF) Phase I study of docetaxel in combination with cyclophosphamide ...
(PDF) Phase I study of docetaxel in combination with cyclophosphamide ...
(PDF) Phase I trial of docetaxel, cisplatin and concurrent radical ...
(PDF) Phase I trial of docetaxel, cisplatin and concurrent radical ...
(PDF) Randomised, non-comparative phase II study of weekly docetaxel ...
(PDF) Randomised, non-comparative phase II study of weekly docetaxel ...
(PDF) Multicenter phase II study of weekly docetaxel, cisplatin, and S ...
(PDF) Multicenter phase II study of weekly docetaxel, cisplatin, and S ...
(PDF) Randomized phase II study of weekly docetaxel plus trastuzumab ...
(PDF) Randomized phase II study of weekly docetaxel plus trastuzumab ...
(PDF) A Phase I study of docetaxel plus cyclophosphamide in solid ...
(PDF) A Phase I study of docetaxel plus cyclophosphamide in solid ...
(PDF) Phase II study of cetuximab in combination with cisplatin and ...
(PDF) Phase II study of cetuximab in combination with cisplatin and ...
(PDF) Dose-finding Study of Docetaxel Added to Ifosfamide and Cisplatin ...
(PDF) Dose-finding Study of Docetaxel Added to Ifosfamide and Cisplatin ...
A phase I pharmacokinetic study of the vascular disrupting agent ...
A phase I pharmacokinetic study of the vascular disrupting agent ...
(PDF) A pilot study of camrelizumab with docetaxel and cisplatin for ...
(PDF) A pilot study of camrelizumab with docetaxel and cisplatin for ...

Loading image details...

Source
Dimensions